期刊
ONCOTARGET
卷 6, 期 27, 页码 23748-23763出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4250
关键词
epithelial ovarian carcinoma; chemoresistance; collagen type XI alpha 1; Akt; PDK1
资金
- National Science Council (NSC) [101-2325-B-006-022, 102-2314-B-006-081]
- National Science Council (MOST) [103-2314-B-006-069]
- Department of Health [102TM1050]
- Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan, ROC
Chemoresistance to anticancer drugs substantially reduces survival in epithelial ovarian carcinoma (EOC). Here, microarray analysis showed that collagen type XI alpha 1 (COL11A1) is a chemotherapy response-associated gene. Chemoresistant cells expressed higher COL11A1 and c/EBP beta than chemosensitive cells. COL11A1 or c/EBP beta downregulation suppressed chemoresistance, whereas COL11A1 overexpression attenuated sensitivity to cisplatin and paclitaxel. The c/EBP beta binding site in the COL11A1 promoter was identified as the major determinant of cisplatin-and paclitaxel-induced COL11A1 expression. Immunoprecipitation and immunofluorescence showed that in resistant cells, Akt and PDK1 were highly expressed and that anticancer drugs enhanced binding activity between COL11A1 and PDK1 binding and attenuated PDK1 ubiquitination and degradation. Conversely, chemosensitive cells showed decreased activity of COL11A1 binding to PDK1 and increased PDK1 ubiquitination, which were reversed by COL11A1 overexpression. Analysis of 104 EOC patients showed that high COL11A1 mRNA levels are significantly associated with poor chemoresponse and clinical outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据